{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:30:34Z","timestamp":1725273034253},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11934-009-0049-0","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T05:18:31Z","timestamp":1246252711000},"page":"302-306","source":"Crossref","is-referenced-by-count":6,"title":["Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Jaspreet S.","family":"Sandhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"49_CR1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/jrf.0.0220573","volume":"22","author":"R.J. Albin","year":"1970","unstructured":"Albin RJ, Soanes WA, Bronson P, Witebsky E: Precipitating antigens of the normal human prostate. J Reprod Fertil 1970, 22:573\u2013574.","journal-title":"J Reprod Fertil"},{"key":"49_CR2","first-page":"4658","volume":"40","author":"M. Kuriyama","year":"1980","unstructured":"Kuriyama M, Wang MC, Papsidero LD, et al.: Quantification of prostate specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980, 40:4658\u20134662.","journal-title":"Cancer Res"},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI112185","volume":"76","author":"H. Lilja","year":"1985","unstructured":"Lilja H: A kallikrein-like serum protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985, 76:1899\u20131903.","journal-title":"J Clin Invest"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI113070","volume":"80","author":"H. Lilja","year":"1987","unstructured":"Lilja H, Oldbring J, Rannevik G, Laurell CB: Seminalsecreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 1987, 80:281\u2013285.","journal-title":"J Clin Invest"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0094-0143(21)00920-4","volume":"20","author":"H. Lilja","year":"1993","unstructured":"Lilja H: Significance of different molecular forms of serum PSA: the free, noncomplexed form of PSA versus that complexed to alpha-1-antichymotrypsin. Urol Clin North Am 1993, 20:681\u2013686.","journal-title":"Urol Clin North Am"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/jama.279.19.1542","volume":"279","author":"W.J. Catalona","year":"1998","unstructured":"Catalona WJ, Partin AW, Slawin KM, et al.: A multicenter clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease. JAMA 1998, 279:1542\u20131547.","journal-title":"JAMA"},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.mjt.0000141604.20320.0c","volume":"11","author":"R. Lieberman","year":"2004","unstructured":"Lieberman R: Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am J Ther 2004, 11:501\u2013506.","journal-title":"Am J Ther"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","volume":"270","author":"J.E. Oesterling","year":"1993","unstructured":"Oesterling JE, Jacobsen SJ, Chute CG, et al.: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 1993, 270:860\u2013864.","journal-title":"JAMA"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000020190","volume":"37","author":"J. Morote","year":"2000","unstructured":"Morote J, Lopez M, Encabo G, de Torres IM: Effect of inflammation and benign prostatic enlargement on total and free serum prostate specific antigen. Eur Urol 2000, 37:537\u2013540.","journal-title":"Eur Urol"},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0022-5347(01)63570-5","volume":"159","author":"D.K. Ornstein","year":"1998","unstructured":"Ornstein DK, Smith DS, Humphrey PA, Catalona WJ: The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percent free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 1998, 159:1234\u20131237.","journal-title":"J Urol"},{"key":"49_CR11","unstructured":"National Institute of Health\/National Institute of Diabetes and Digestive and Kidney Diseases Workshop on Chronic Prostatitis: National Institutes of Health Summary Statement. Executive Summary. Bethesda, MD; 1995."},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0090-4295(99)00205-8","volume":"54","author":"J.C. Nickel","year":"1999","unstructured":"Nickel JC, Nyberg LM, Hennenfent M: Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999, 54:229\u2013233.","journal-title":"Urology"},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0022-5347(05)68090-1","volume":"162","author":"L.D. True","year":"1999","unstructured":"True LD, Berger RE, Rothman I, et al.: Prostate histopathology and chronic prostatitis\/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 1999, 162:2014\u20132018.","journal-title":"J Urol"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-5347(05)63959-6","volume":"169","author":"B.S. Carver","year":"2003","unstructured":"Carver BS, Bozeman CB, William BJ, Venable DD: The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003, 169:589\u2013591.","journal-title":"J Urol"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(00)00519-7","volume":"55","author":"K. Okada","year":"2000","unstructured":"Okada K, Kojima M, Naya Y, et al.: Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000, 55:892\u2013898.","journal-title":"Urology"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2004.08.003","volume":"46","author":"I. Stancik","year":"2004","unstructured":"Stancik I, Luftenegger W, Klimpfinger M, et al.: Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004, 46:760\u2013764.","journal-title":"Eur Urol"},{"key":"49_CR17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1464-410X.2006.06132.x","volume":"97","author":"W.E. Rowe","year":"2006","unstructured":"Rowe WE, Laniado ME, Walker MM, Anup P: Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study. BJU Int 2006, 97:1039\u20131042.","journal-title":"BJU Int"},{"key":"49_CR18","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","volume":"167","author":"C.B. Bozeman","year":"2002","unstructured":"Bozeman CB, Carver BS, Eastham JA, Venable DD: Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002, 167:1723\u20131726.","journal-title":"J Urol"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0022-5347(05)67026-7","volume":"164","author":"J.M. Potts","year":"2000","unstructured":"Potts JM: Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000, 164:1550\u20131553.","journal-title":"J Urol"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.urology.2005.08.031","volume":"67","author":"R.B. Nadler","year":"2006","unstructured":"Nadler RB, Collins MM, Propert KJ, et al.: Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis\/chronic pelvic pain syndrome. Urology 2006, 67:337\u2013342.","journal-title":"Urology"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1001\/jama.289.20.2695","volume":"289","author":"J.A. Eastham","year":"2003","unstructured":"Eastham JA, Riedel E, Scardino PT, et al.: Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 2003, 289:2695\u20132700.","journal-title":"JAMA"},{"key":"49_CR22","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.juro.2009.01.029","volume":"181","author":"D.P. Ankerst","year":"2009","unstructured":"Ankerst DP, Miyamoto R, Nair PV, et al.: Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population. J Urol 2009, 181:2071\u20132075.","journal-title":"J Urol"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urolonc.2008.04.002","volume":"27","author":"S. Loeb","year":"2009","unstructured":"Loeb S, Gashti SN, Catalona WJ: Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urol Oncol 2009, 27:64\u201366.","journal-title":"Urol Oncol"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncpuro0702","volume":"4","author":"P.T. Scardino","year":"2007","unstructured":"Scardino PT: The responsible use of antibiotics for an elevated PSA level. Nat Clin Pract Urol 2007, 4:1.","journal-title":"Nat Clin Pract Urol"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(01)62255-9","volume":"160","author":"L.V. Rodriquez","year":"1998","unstructured":"Rodriquez LV, Terris MK: Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998, 160:2115\u20132020.","journal-title":"J Urol"},{"key":"49_CR26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1464-410x.2000.00576.x","volume":"85","author":"M. Aron","year":"2000","unstructured":"Aron M, Rajeev TP, Gupta NP: Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000, 85:682\u2013685.","journal-title":"BJU Int"},{"key":"49_CR27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","volume":"179","author":"J. Feliciano","year":"2008","unstructured":"Feliciano J, Teper E, Ferrandino M, et al.: The incidence of fluoroquinolone resistant infections after prostate biopsy: are fluoroquinolones still effective prophylaxis? J Urol 2008, 179:952\u2013955.","journal-title":"J Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-009-0049-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-009-0049-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-009-0049-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:24:00Z","timestamp":1633649040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-009-0049-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,30]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s11934-009-0049-0","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,30]]}}}